Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

S. R. Verhoeff; S. Es; E. Boon; E. van Helden; L. Angus; S. Elias; S. Oosting; E. Aarntzen; A. Brouwers; S. Heskamp; O. S. Hoekstra; H. M. Verheul; A. A.M. Van der Veldt; E. G.E. de Vries; O. Boerman; W. T.A. van der Graaf; W. J.G. Oyen; C. M.L. van Herpen

doi:10.1093/annonc/mdy283.097

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

S. R. Verhoeff, S. Es, E. Boon, E. van Helden, L. Angus, S. Elias, S. Oosting, E. Aarntzen, A. Brouwers, S. Heskamp, O. S. Hoekstra, H. M. Verheul, A. A.M. Van der Veldt, E. G.E. de Vries, O. Boerman, W. T.A. van der Graaf, W. J.G. Oyen, C. M.L. van Herpen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii314-viii315
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy283.097
Publication status	Published - 1 Oct 2018

Access to Document

10.1093/annonc/mdy283.097

Cite this

Verhoeff, S. R., Es, S., Boon, E., van Helden, E., Angus, L., Elias, S., Oosting, S., Aarntzen, E., Brouwers, A., Heskamp, S., Hoekstra, O. S., Verheul, H. M., Van der Veldt, A. A. M., de Vries, E. G. E., Boerman, O., van der Graaf, W. T. A., Oyen, W. J. G., & van Herpen, C. M. L. (2018). Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii314-viii315. https://doi.org/10.1093/annonc/mdy283.097

@article{2b3fb2cd86e2422c8b5d51435ad19c98,

title = "Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)",

author = "Verhoeff, {S. R.} and S. Es and E. Boon and {van Helden}, E. and L. Angus and S. Elias and S. Oosting and E. Aarntzen and A. Brouwers and S. Heskamp and Hoekstra, {O. S.} and Verheul, {H. M.} and {Van der Veldt}, {A. A.M.} and {de Vries}, {E. G.E.} and O. Boerman and {van der Graaf}, {W. T.A.} and Oyen, {W. J.G.} and {van Herpen}, {C. M.L.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy283.097",

language = "English",

volume = "29",

pages = "viii314--viii315",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Verhoeff, SR, Es, S, Boon, E, van Helden, E, Angus, L, Elias, S, Oosting, S, Aarntzen, E, Brouwers, A, Heskamp, S, Hoekstra, OS , Verheul, HM, Van der Veldt, AAM, de Vries, EGE, Boerman, O, van der Graaf, WTA, Oyen, WJG & van Herpen, CML 2018, 'Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii314-viii315. https://doi.org/10.1093/annonc/mdy283.097

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). / Verhoeff, S. R.; Es, S.; Boon, E. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii314-viii315.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

AU - Verhoeff, S. R.

AU - Es, S.

AU - Boon, E.

AU - van Helden, E.

AU - Angus, L.

AU - Elias, S.

AU - Oosting, S.

AU - Aarntzen, E.

AU - Brouwers, A.

AU - Heskamp, S.

AU - Hoekstra, O. S.

AU - Verheul, H. M.

AU - Van der Veldt, A. A.M.

AU - de Vries, E. G.E.

AU - Boerman, O.

AU - van der Graaf, W. T.A.

AU - Oyen, W. J.G.

AU - van Herpen, C. M.L.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531907&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy283.097

DO - 10.1093/annonc/mdy283.097

M3 - Article

C2 - 32136732

SN - 0923-7534

VL - 29

SP - viii314-viii315

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Access to Document

Other files and links

Cite this